跳至主要内容
临床试验/NCT03560687
NCT03560687已完成不适用

CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation

Cardiochirurgia E.H.1 个研究点 分布在 1 个国家目标入组 1,023 人开始时间: 2018年10月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,023
试验地点
1
主要终点
Preoperative Hemoglobin Level

研究概览

简要总结

This randomized, single blind (Outcomes Assessor), non-profit study is aimed at verifying whether routine preoperative supplementation with Sucrosomial® Iron in patients scheduled for cardiac surgery may increase baseline haemoglobin, constrain the haemoglobin decrease between postoperative day 2 and 3 (haemoglobin drift), and reduce the postoperative transfusion requirements, in order to identify a new strategy for pre-hospitalization optimization and post-operative recovery.

详细描述

This randomized, single blind (Outcomes Assessor), non-profit study is aimed at verifying whether routine preoperative supplementation with Sucrosomial® Iron in patients scheduled for cardiac surgery may increase baseline haemoglobin, constrain the haemoglobin decrease between postoperative day 2 and 3 (haemoglobin drift), and reduce the postoperative transfusion requirements, in order to identify a new strategy for pre-hospitalization optimization and post-operative recovery.

Secondary Objectives are

  • Changes in blood chemistry and biochemical tests between pre- and post-intervention
  • Evaluation of tolerability and compliance of supplementation with Sucrosomal Iron
  • Reduction in the number of transfusions and blood bags used
  • Evaluation of cost-effectiveness

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Single blinded

入排标准

性别
All
接受健康志愿者

入选标准

  • Undergoing elective Heart Surgery -

排除标准

  • Emergent or Urgent Indication

研究组 & 干预措施

CardioSIDERAL

Experimental

Adminsitration of 2 pills per day of CArdiosideral from 30 days before operation to time of operation

干预措施: Sucrosomial Iron (Drug)

结局指标

主要结局

Preoperative Hemoglobin Level

时间窗: 30 days from enrollment

Preoperative Hemoglobin Level

次要结局

  • Compliance to drug(30 days from enerollemnt)
  • Cost-effectiveness in terms of cost of drug vs saved blood units(30 days after operation)
  • Hemoglobin Level 24 hours after operation(24 hours after index operation)
  • Hemoglobin Level 48 hours after operation(48 hours after index operation)

研究者

发起方
Cardiochirurgia E.H.
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luca Weltert

Clinical Professor, Principal Investigator

Cardiochirurgia E.H.

研究点 (1)

Loading locations...

相似试验